A series of structurally related antiviral antibiotics, fluvirucins Al9 A2, B1? B2, B3, B4 and B5 have been isolated from the fermentation broths of five unidentified actinomycete isolates. Based on spectroscopic analysis, partial degradation experiments and 1 3C-enriched acetic acid-fed biosynthetic studies, their structures were elucidated to be 2,6,10-trialkyl-3(or 9)-aminoglycosyl-13-tridecanelactams.
In the course of our fermentation screening for agents with activity against influenza A virus, five soil actinomycete strains were discovered to produce active agents with closely related structures. These were designated fluvirucins A1 (1), A2 (2), Bx (3), B2 (4), B3 (5), B4 (6) and B5 (7) . In the preceding paper1}, the preliminary taxonomical study of the producing strains and production, isolation, physico-chemical (1) was available in the largest quantities, structural studies were first focused on this compound. Thestructures of the other componentswere determined on the basis of spectroscopic and degradation correlation to fluvirucin AT he FAB-MS(m/z 429, (M+H)) and elemental analysis of 1 established its molecular formula as C23H44N2O5.This assignment was corroborated by its triacetate (8: C29H50N2O8m/z 554, M) obtained by acetylation of 1 in pyridine. The 13C NMRspectrum of 8 displayed 29 signals (Table 1 ) including 4 methyl, 9 methylene, 9 methine and one carbonyl carbon in addition to 6 carbons attributable to three acetyl groups (3 20.8, 21.1, 23.2, 169.5, 170.5 and 170.7). The carbonyl group of 8 was considered to be an amide function from the 13C NMRchemical shift (3 174.1) and the IR absorption (1635 and 1540cm" x) of 1. The presence ofa sugar moiety was suggested by the XHNMRspectra of 1 and 8 (anomeric proton:
Structure of Fluvirucinine Ax (9), the Aglycone of Fluvirucin Ax Whenheated with 5 n methanolic hydrogen chloride, 1 afforded a crystalline aglycone (fluvirucinine Ax: 9) and a methyl glycoside (10). 9 possessed the IR absorption at 1640 and 1545 observed for 1 and was assigned a molecular formula ofC17H33NO2by MS(m/z 283, M) and microanalysis. Upon acetylation 9 gave a mono-0-acetate (ll: m/z 325, M, vc=o cm"1 1730) and on pyridinium dichromate oxidation a keto derivative (12: m/z 281, M, vc=o cm"1 1720). The 13C and XH NMRspectra of ll showed 4 methyl, 9 methylene, 4 methine and 2 carbonyl groups. Most of them were analyzed as the partial structure illustrated in Fig. 2 by XHNMRand WH2D-COSYspectra. In order to further expand the carbon skeleton sequence of 9 by 2D-incredible natural abundance double quantum transfer experiment (INADEQUATE), it was converted to a more soluble JV,O-dimethyl derivative (13: C19H37NO2 m/z 31 1, M) by Hakomori's permethylation method2). Starting from the C-l carbonyl carbon signal at 3 174.5 the 13C-13C connectivities were established up to the Oil methylene carbon at 3 27.1, including the three side chains at C-2 (methyl), C-6 (methyl) and C-10 (ethyl). On the other hand, the amide nitrogen-bearing methylene carbon at 3 48.0 (C-l3) was proved to be adjacent to the methylene carbon at 3 23.3 (C-12).
The results are also summarized in Fig. 2 . From this experiment, 2,6-dimethyl-10-ethyl-3-hydroxy-13-tridecanelactam structure for 9 became reasonable by linking C-l l and C-12 methylenes, and the carbonyl and nitrogen although a direct correlation between them was not observed in the spectra.
Structure of Sugar 10 Methyl glycoside 10 was separated into, the major a-methyl glycoside (10a) and minor jS-methyl glycoside (10b) by preparative TLC followed by ion exchange chromatography. The ammonia-added EI-MS (m/z 178, (M+H)) and microanalysis established their molecular formula as C7H15NO4. Their XH NMR and 2D-COSY spectra allowed the assignment of methyl a-and j8-3-amino-3,6-dideoxytalopyranosides to 10a and 10b, respectively. Although this sugar has been chemically synthesized3), its isolation from natural sources has not been reported. By comparison of the optical rotational value of 10b (+35°in H2O) with literature data, the sugar was established as the l-series.
For confirmation of the structure, methyl 3-amino-3,6-dideoxy-a-D-talopyranoside was synthesized from methyl a-mycosaminide obtained by acid methanolysis of amphotericin B4'5). Methyl a-mycosaminide was N-acetylated, O-mesylated, and then heated with sodium acetate in 2-methoxyethanol to convert its 4-hydroxyl from trans to cis with respect to 3-amino group6>7). Re-<9-mesylation of the product yielded methyl 3-acetamido-3,6-dideoxy-2,4-di-0-mesyl-a-D-talopyranoside which was identical with the 7V-acetyl-0,0-dimesyl derivative of 10a in chemical and spectral data. CDspectra of these two sugar derivatives, however, exhibited opposite Cotton curves indicating that 10a is l.
Structure of Fluvirucin A1 (1) Fluvirucinine Al (9) has only one hydroxyl group at C-3 and therefore sugar 10 should be liked to the C-3 hydroxyl group by a glycoside linkage in 1. In the 13C NMRspectrum, C-3 carbon of8 exhibited significant down field shift, and C-2 and C-4 carbons up field shifts compared to those of 9 supporting the assumption. In the XHNMRspectra, the anomeric protons of both 10a and 10b appeared as narrow doublets (/= 1.1 Hz) indicating that the bond angle between the anomeric proton and C-2 proton is about 60°in both anomers. The anomeric protons of 1 and 8 were also observed as a narrow doublet (/= 1.3 Hz) and a broad singlet, respectively, which precluded application of the general rule of proton splitting for the assignment of sugar configuration. The anomeric protons of 1 and 8, however, resonated at relatively low field (S 4.87 and 4.96, respectively) suggesting the a-configuration.
In the 13C NMRspectrum, the anomeric carbon of 8 was observed at S 99.0, nearly identical with that of 10a and its 13C-XHcoupling constant value measured by insensitive nuclear enhanced polarization transfer (INEPT) was 7= 170 Hz. These results clearly show that sugar 10 has the a-pyranoside configuration in 1. Thus the whole structure of fluvirucin Ai was established as shown in Fig. 1 . This structure was confirmed by X-ray crystallographic analysis of 8 as described in the following paper8 When acetylated in pyridine, 15 afforded a di-0-acetyl derivative (16), whose NMRspectra including 2D-COSYdisclosed that a hydroxyl and a a-hydroxyethyl are at C-3 and C-2, respectively. Other spectral data of 16, 14 and 2 corresponded well with those of ll, 8 and 1. (Tables 1 and 2) Structure of Fluvirucin Bx (3) As discussed in the previous paper, though the seven fluvirucin components are quite similar to each other, the physico-chemical data and biological activity of 3 differ significantly from those of 1 and 2, and much resemble those of 4 and 5. The molecular formula of 3 (C24H46N2O5)is larger than that of 1 by CH2. Twotriplet methyls and two doublet methyls were observed in the *H NMRspectrum of3 in contrast to one triplet methyl and three doublet methyls in that of Structure of Fluvirucin B2 (4) The physico-chemical and biological properties of 4 were similar to those of 3 and the molecular formula of4 (C25H48N2O5)was a CH2more than that of3. This, combined with the *H NMRspectrum of its triacetyl derivative 25 which exhibited one doublet methyl and three triplet methyls, suggested substitution of an ethyl group at C-6 on the core ring in 4 instead of the methyl group in 3. In the 13C NMRspectra of 17 and 25, the C-6 carbon of 25 was observed at 7.4ppm lower field than that of 17, supporting the assigned C-6 ethyl substitution, and the other parts of the aglycone were identical. 4 was hydrolyzed in methanolic hydrogen chloride to yield fluvirucinine B2 (26: C19H37NO2)and a-and /^-methyl glycosides of a sugar (27a and 27b). The XHNMRspectrum of monoacetylfluvirucinine B2 (28) displayed three triplet methyls (S 0.81, 0.82 and 0.88), and the chemical shifts of the other protons of 28 agreed with those of 19 ( Table 2) . Sugar 27a was identical with methyl a-D-mycosaminide5) in physico-chemical and spectral properties, but its optical rotational value (27a: [a]D -47°) was opposite in sign to that of the latter ([a]D + 54°)5). Thus, the sugar of 4 was determined to be L-mycosamine. The a-pyranoside structure of the sugar was established by XHand 13C NMRanalysis of25 including an INEPTspectrum for analysis of the anomeric configuration (169 Hz).
Structures
of Fluvirucins B3 (5), B4 (6) and B5 (7) The XH NMRspectra of5, 6 and 7 and their acetates (29, 30 and 31, respectively) and the 13C NMR spectra of these acetates indicated that the three components had the same aglycone (fluvirucinine B2, 26) as 4 and acid methanolysis of them in fact produced 26 in quantitative yield.
5 was identical in molecular formula (C25H48N2O5)to 4, and upon methanolysis, yielded an anomeric mixture of methyl 3-amino-3,6-dideoxy-L-talopyranoside (10a and 10b) in addition to 26. These data coupled with the NMRdata allowed us to assign 4/-e/?/-fluvirucin B2 structure to 5. 6 and 7 showed the same molecular formula (C34H57N3O6)and, unlike other components, they were negative to ninhydrin test. Their IR spectra indicated amide carbonyl absorptions (vc=o cm" 1 1640 and 1560) and their UV spectra (Amax nm 246, 252, 258, 264 and 268) revealed a phenyl chromophore. XH and 13C NMR (Table 1 ) and 2D-COSYspectra of30 and 31 revealed that a 2-phenethylureide was attached to the 3'-amino group of the sugar moiety. Actually, 2-phenethylamine (32) was recovered from the total acid hydrolysate of 6 and 7. Furthermore, acid methanolysis of 6 yielded an anomeric mixture of methyl 3-7V-(2-phenethylaminocarbonyl)-L-mycosaminides (33) in addition to 26, whereas 7 gave the 3-iV-(2-phenethylaminocarbonyl) derivatives of methyl a-and /?-3-amino-3,6-dideoxy-L-talopyranoside mixture (34) together with 26 by the hydrolysis. Interpretation of these spectral data and degradation results led to the complete structures of6 and 7 as in Fig. 1 .
Biosynthetic
Study of Fluvirucin A1 (1) In order to confirm the assigned 14-memberedlactam structure and to elucidate the biosynthetic only C-ll, this C-3 unit was likely to be derived from an intermediate in the Kreb's cycle produced by decarboxylation of succinate or its equivalent. There have been reported several examples of incorporation of the advanced precursors into polyketide biosynthesis9) and fluvirucin is considered to be an additional example. The labeling pattern resulting from these experiments is shown in Fig. 4 . Fluvirucinines A2, B1 and B2 differ structurally from fluvirucinine A1 at C-l~2-CH3 and C-5~6-CH3 parts. This shows these moieties are the variable parts in the biosynthesis and can be replaced by other units (butyrates etc.) instead of propionates of fluvirucin Av The biosynthetic experiments fully supported the 2,6,10-trialkyltridecanelactam structures assigned for fluvirucins.
Discussion
The structures of fluvirucins A1? A2, B1? B2, B3, B4 and B5 were shown by chemical, spectral and biosynthetic experiments to be a unique 2,6, 10-trialkyl-3 (or 9)-hydroxy-1 3-tridecanelactam core substituted with L-mycosamine or 3-amino-3,6-dideoxy-L-talose at the C-3 or C-9 hydroxyl Fluvirucin components differ from each other in the alkyl substituents at C-2 or C-6, the position of the hydroxyl and/or the aminosugar. Fluvirucins B4 and B5 have an unusual 2-phenethylaminocarbonyl substitution at the amino group of the sugar.
The four aglycones offluvirucins retain the anti-influenza A virus activity with potency being one-fourth to one-eighth that of the original antibiotics. The Af-acylated representatives, fluvirucins B4 and B5 were bioinactive and 7V-acetylation of other components also resulted in bio-inactive derivatives. Therefore, the free amino group of the antibiotics is considered to be crucial for expression of the antiviral activity.
After we completed the structural studies on fluvirucins, a closely related antibiotic Sch 38516 was reported10). Although we have not yet determined the stereochemistry of the lactam ring of fluvirucin B series, fluvirucin Bl is identical with Sch 38516 in 2D structure.
Experimental
General TLC was performed on precoated Silica gel 60 F254 plates (E. Merck, Darmstadt, No. 5715 or 5744). The IR spectra were determined on a Jasco IR-810 and the UVspectra on a UVIDEC-610Cspectrometer. The *H NMRand 13C NMRspectra were recorded on a Jeol JNM-GX 400. The mass spectra were obtained with a Hitachi M-80B (El) or a Jeol JMS-AX505H (El and FAB). Optical rotations were determined with a Jasco model DIP140. The mp's were recorded on Yanagimoto MP-2S and are un- Acetylation of Fluvirucin Ax (1) 1 (1 18 ing) was stirred with acetic anhydride (2ml) in anhydrous pyridine (3 ml) for 16 hours at room temperature. To the reaction mixture, ethyl acetate (70 ml) and ice-water were added and the mixture was stirred for 1 hour. After washing with 1 m aqueous CuSO4(50ml) and water, the organic layer was concentrated to give a pale yellow solid. This was charged on a column of WakogelC-200 (50ml) which was eluted with toluene -methanol (19 : 1). The fractions containing the desired acetate were collected and evaporated under reduced pressure to give a white powder of the triacetate (8, 149 mg). It was crystallized as colorless rods from acetone. The filtrate and the wash were combined, diluted with water to 400 ml and then washed with butanol (200ml). The aqueous layer was concentrated to 100ml in vacuo, neutralized with Amberlite IRA-400 (OH") and charged on a column of Amberlite CG-50 (NH4). Upon elution with 0.2n NH4OH, the fractions which showed a positive ninhydrin test were collected and concentrated to give a white solid (145mg) of 10. 10 was separated to the major methyl a-glycoside (10a) and minor /?-anomer (10b) by preparative TLC developed by chloroform-ethanol-28% NH4OH(4: 7 : 2). After Amberlite CG-50 chromatography, homogeneous 10a (106mg) and 10b (20mg) were obtained as white solids. Acid Methanolysis of Fluvirucin B2 (4) 4 was hydrolyzed with methanolic hydrogen chloride and the products were worked up as described for 1 to yield aglycone 26 and methyl L-mycosaminide mixture 27a and 27b. In similar fashion, 5 yielded aglycone 26 and sugars 10a and 10b.
Acid Methanolysis of Fluvirucins B4 (6) and B5 (7) Acid methanolysis of 6 and 7 by the procedure described above gave methyl glycosides 33 and 34, respectively, and aglycone 26. Acetylation of Fluvirucinine KY(9) 9 (43 mg) was reacted with acetic anhydride (1 ml) in anhydrous pyridine (3 ml) for 16 hours at room temperature. The crude product was purified by column chromatography on Wakogel C-200 using a solvent system of toluene -methanol (49 : 1). The relevant fractions were collected and concentrated to afford a white powder (50mg) of the acetate (ll). This was crystallized from methanol to give colorless In an analogous manner, 15, 18 and 26 were acetylated to acetates 16, 19 and 28, respectively.
Oxidation of Fluvirucinine A1 (9) 9 (64.5 mg) and pyridinium dichromate (PDC, 100 mg) were suspended in dichloromethane (100 ml) and stirred for 32 hours at room temperature. After removal of the insolubles by filtration, the filtrate was concentrated under reduced pressure to give a brownish solid. This product was chromatographed on Wakogel C-200 using toluene -methanol (49 : 1) as eluent. After TLC examination, the relevant fractions were concentrated to afford a white solid (32mg) of 12. Some starting material (16mg) was recovered from the following eluate. 12 was crystallized from methanol as colorless needles. 1H each, m, 4-H2), 3.16, 3.34 (1H each, m, 13-H2 To a solution of sodium dimethylsulfinyl anion prepared from NaH(20g of 50% oil suspension) and DMSO(200ml), 9 (890mg) and CH3I (90ml) were added and the mixture was stirred in argon stream for 1 hour at room temperature. After dilution with water, the methylated product was extracted with chloroform. Theextract wasconcentrated in vacuo and the residue subjected to mediumpressure column chromatography (E. Merck, TLC Silica gel 60 H, No. 11695) eluted with hexane-acetone (19 : 1). A white solid of 13 (727mg) was obtained by evaporation of the appropriate fractions. 6-H3), 1.99 (3H, s, NAc). It (61 mg) was reacted with methanesulfonyl chloride (0.25ml) in anhydrous pyridine (2 ml) at room temperature. The reaction mixture was diluted with ice-water and extracted with ethyl acetate. After washing successively with 1 n HC1, aqueous NaHCO3, and water, the extract was evaporated to dryness to afford the crude mesylate. This was purified by preparative TLCdeveloped with chloroform-methanol (9 : 1) followed by Sephadex LH-20 chromatography and then by crystallization from acetone-rc-hexane to give colorless rods of the mesylate (58mg) A solution of the mesylate (56 mg) and anhydrous sodium acetate (100 mg) in 2-methoxyethanol (20 ml) was refluxed for 3 days. The solution was evaporated and the residue was partitioned between ethyl acetate and water (50ml each). The organic layer was concentrated under reduced pressure. The residue was mesylated again with mesyl chloride in anhydrous pyridine. The crude product was purified by preparative TLC and Sephadex LH-20 chromatography to yield a white powder of methyl 3-acetamido-3,6-dideoxy- 
